Medical Device Testing Services Industry Landscape & Scope Till, 2022 - 2030

The global medical device testing services market is expected to reach USD 22.8 billion by 2030, registering a CAGR of 11.3% during the forecast period, according to a new report by Grand View Research, Inc. increasing complexity in product design and stringent government regulations are driving demand for the medical device testing services. The COVID-19 pandemic has created an unprecedented demand for medical device testing services in 2020, and the trend was expected to continue in 2021. The majority of medical equipment being tested is Personal Protective Equipment (PPE).

A significant rise in preclinical spending is a recent trend among pharmaceutical and medical device companies, which is expected to significantly contribute to market growth. As per the survey carried out by the International Federation of Pharmaceutical Manufacturers & Associations in 2017, around USD 149.8 billion is spent on preclinical trials, every year.

Medical Device Testing Services Market Segmentation

Grand View Research has segmented the global medical device testing services market based on the service, phase, and region:

Based on the Service Insights, the market is segmented into Biocompatibility Tests, Chemistry Test, Microbiology & Sterility Testing and Package Validation.

• Microbiology and sterility testing dominated the market with 34.2% of revenue share in 2021. The segment is further divided into bioburden determination, pyrogen & endotoxin testing, sterility test &validation, and anti-microbial activity testing.
• Package & validation for medical devices ensure product integrity and protect against damage throughout the supply chain. Though the market is less monopolized and accounted for 14.0% of the revenue share in 2021.
• The manufacturers are now considering environmental and economic factors to revalidate their packaging. Also, regulatory authorities such as FDA have increased their focus on medical device packaging, which is acting as a driving force behind the market growth.

Based on the Phase Insights, the market is segmented into Preclinical, and Clinical.

• The preclinical phase led the market and accounted for more than 65.0% share of the global revenue in 2021. The segment is also expected to dominate the market during the forecast period, as the major portion of biocompatibility, microbiology, and chemistry tests are performed in this phase.
• Medical device testing services during the clinical trial phase are expected to grow significantly in the coming years. As medical devices are critical they have a direct impact on human lives.

Medical Device Testing Services Regional Outlook

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa (MEA)

Key Companies Profile & Market Share Insights

Being a very competitive market space, companies are increasing their emphasis in certain areas. For example, in 2021, TÜV SÜD announced that it would present itself at Medtec LIVE, to exhibit its ability to be a one-stop shop for medical device testing.

Some prominent players in the global medical device testing services market include:

• SGS SA
• Toxikon, Inc
• Euro fins Scientific
• Pace Analytical Services LLC
• Intertek Group Plc
• Wuxi AppTec
• North American Science Associates, Inc
• TÜV SÜD AG
• American Preclinical Services
• Sterigenics International LLC
• Charles River Laboratories International, Inc.
• Medical Device Testing Services

Order a free sample PDF of the medical device testing services Market Intelligence Study, published by Grand View Research.